1e
In Memoriam
16
19
1
49
2
2
18
1b
1d
18
32
2b
7
61
1d
2 29
1d
25
Kwaku Ohene-Frempong
88
2b
7
61
Department: Pediatrics
4
1
b
1d
46
Contact information
44
4
3
3
3
2
4
b
1f
44
Division of Hematology
31 The Children's Hospital of Philadelphia
45 34th Street & Civic Center Blvd.
Philadelphia, PA 19104
26
31 The Children's Hospital of Philadelphia
45 34th Street & Civic Center Blvd.
Philadelphia, PA 19104
2c
Office: 2159779779
30
9b
12
30
13
Education:
21 9 B.S. 16 ((Biology)) c
29 Yale University , 1970.
21 9 M.D. e (?) c
28 Yale University, 1975.
c
3
3
3
3
8b
Permanent link21 9 B.S. 16 ((Biology)) c
29 Yale University , 1970.
21 9 M.D. e (?) c
28 Yale University, 1975.
c
2 29
21
1e
1d
24
2b
29
27
23
7a Iyamu EW, Adunyah SE, Fasold H, Horiuchi K, Baliga S, Ohene-Frempong K, Turner ea EA, Asakura T: Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line. Exp Hematol. 31(7): 592-600, 2003.
81 Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stallings VA: Effect of zinc 6b supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 25 75: 300-7, 2002.
159 Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles L, Helms RW, Kinney TR, Ohene-Frempong K: Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99(1): 10-14, 2002.
76 Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, f0 Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR: Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 140(2): 225-9, 2002.
201 Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 140(3): 348-54, 2002.
e7 Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS: Body composition in children with sickle cell disease. Am J Clin Nutr. 76(1): 218-25, 2002.
73 Nelson MC, Zemel BS, Kawchak DA, Barden EM, Frongillo EA Jr, Coburn SP, a6 Ohene-Frempong K, Stallings VA: Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol. 24(6): 463-9, 2002.
12c Katz ML, Smith-Whitley K, Ruzek SB, Ohene-Frempong K: Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers. Ethn Health. 7(2): 115-23, 2002.
11a Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA: Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol/Oncol 23(3): 165-9, 2001.
2c
7
1d
1f
Selected Publications
108 Kwiatkowski JL, Hunter JV, Smith-Whitley K, Katz ML, Shults J, Ohene-Frempong K: Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol 121(6): 932-7, 2003.7a Iyamu EW, Adunyah SE, Fasold H, Horiuchi K, Baliga S, Ohene-Frempong K, Turner ea EA, Asakura T: Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line. Exp Hematol. 31(7): 592-600, 2003.
81 Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stallings VA: Effect of zinc 6b supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 25 75: 300-7, 2002.
159 Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles L, Helms RW, Kinney TR, Ohene-Frempong K: Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99(1): 10-14, 2002.
76 Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, f0 Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR: Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 140(2): 225-9, 2002.
201 Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 140(3): 348-54, 2002.
e7 Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS: Body composition in children with sickle cell disease. Am J Clin Nutr. 76(1): 218-25, 2002.
73 Nelson MC, Zemel BS, Kawchak DA, Barden EM, Frongillo EA Jr, Coburn SP, a6 Ohene-Frempong K, Stallings VA: Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol. 24(6): 463-9, 2002.
12c Katz ML, Smith-Whitley K, Ruzek SB, Ohene-Frempong K: Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers. Ethn Health. 7(2): 115-23, 2002.
11a Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA: Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol/Oncol 23(3): 165-9, 2001.
2c